Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...

Liver transplant candidates may get a fairer shake from an artificial intelligence-based organ allocation system than that offered by the current Model for End-Stage Liver Disease (MELD) scoring ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patient survival was no different for living donor liver transplant recipients with a MELD score ...

Please provide your email address to receive an email when new articles are posted on . Replacing serum creatinine with estimated glomerular filtration rate in a patient’s MELD-Na score appeared to ...

Since its proposal, the Model for End-Stage Liver Disease (MELD) score has been employed to predict short-term mortality among patients with chronic liver disease and those awaiting liver ...

During the 3-month follow up, 223 patients died. The causes of death were all related to liver disease: 49 patients died of hepatorenal syndrome; 117 patients died of hepatic encephlophy; 44 patients ...

Laboratory traits used in the calculation of sodium-adjusted model for end-stage liver disease (MELDNa) scores placed women at a distinct disadvantage, researchers reported. In an electronic health ...

The Model for End-stage Liver Disease (MELD) score—derived from serum total bilirubin and creatinine levels, plus the international normalized ratio—is commonly used in the US to assess patients' ...

Prognostic scores are valuable tools for predicting survival in patients with chronic liver disease. Recently, the albumin-bilirubin (ALBI) score has emerged as a potential prognostic indicator in ...

Before joining IBM Research in Cambridge in September 2016, I completed a three-year postdoctoral training program at Massachusetts General Hospital (MGH), working closely with Harvard faculty. Now, a ...

Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...